No Questions Asked

Graveline, Duane
August 2012
PN;Aug2012, Vol. 66 Issue 8, p21
Trade Publication
The author discusses statins as hypocholesterolemics. Statins result in a drop in cholesterol, but the reduction of cholesterol leads to severe cognitive dysfunction in many a statin user, since cholesterol is vital to the formation and function of memory synapses in the brain. It was also discovered that the positive effects on some cases of cardiovascular disease had, after all nothing to do with statin use. The author questions the use of statins for lowering cholesterol levels.


Related Articles

  • Statin induced myopathy. Sathasivam, Sivakumar; Lecky, Bryan // BMJ: British Medical Journal (International Edition);11/15/2008, Vol. 337 Issue 7679, p1159 

    The article discusses statin induced myopathy. The author explains that the term myopathy is used for the entire spectrum of muscle related adverse events including myalgia, myositis, and rhabdomyolysis. Clinical features including muscle tenderness, muscle pain, and tendon pain are listed. The...

  • Atorvastatin.  // Reactions Weekly;4/24/2010, Issue 1298, p11 

    The article describes the case of an 80-year old woman who developed myopathy while undergoing treatment with atorvastatin.

  • Diltiazem/simvastatin interaction.  // Reactions Weekly;2/19/2011, Issue 1339, p18 

    The article describes the case of a 59-year-old man who developed rhabdomyolysis after receiving concomitant oral simvastatin for hypercolesterolemia and coronary heart disease and oral diltiazem for angina pectoris.

  • A Neuromuscular Approach to Statin-Related Myotoxicity. Baker, Steven K.; Samjoo, Imtiaz A. // Canadian Journal of Neurological Sciences;Mar2008, Vol. 35 Issue 1, p8 

    Approximately 95% of statin-treated patients tolerate this form of cholesterol management without any adverse effects. However, given their efficacy in reducing low density lipoproteins and cardiovascular events large numbers of patients are selected for statin therapy. Therefore muscle...

  • Do You Need a Statin? WAIT, MARIANNE // Arthritis Today;Mar/Apr2014, Vol. 28 Issue 2, p32 

    The article focuses on new treatment guidelines for preventing cardiovascular disease (CVD) that aims at treating rheumatoid arthritis (RA) patients without using statin including online risk calculator which considers factors such as age, gender, blood pressure and cholesterol levels.

  • Contemporary Evidence-Based Guidelines: Practice Based on the Strongest Evidence. Robinson, Jennifer G. // Mayo Clinic Proceedings;Sep2014, Vol. 89 Issue 9, p1176 

    The author discusses guidelines issued in 2013 by the American College of Cardiology (ACC) and the American Heart Association (AHA) regarding the treatment of blood cholesterol to reduce atherosclerotic risk and the assessment of cardiovascular risk. Topics covered include recommendations for...

  • PCSK9 Inhibitors: Are We on the Verge of a Breakthrough? Yang, E. // Clinical Pharmacology & Therapeutics;Dec2015, Vol. 98 Issue 6, p590 

    Statins are first-line therapy for lowering cholesterol and reducing cardiovascular events. A significant need for new lipid-modifying therapies remains for patients unable to tolerate statins or achieve guideline-based cholesterol targets. Proprotein convertase subtilisin/kexin type 9 (PCSK9)...

  • Statin prescribing and diabetes. Morris, David // Independent Nurse;Jun2015, p31 

    No abstract available.

  • Re: Statin use in older patients. Mudaliar, Adi // British Columbia Medical Journal;Mar2014, Vol. 56 Issue 2, p81 

    A letter to the editor is presented in response to an article on the use of statin for the older people in reducing cardiovascular risks in the previous issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics